close

Make a Payment

Provider Portal

Portal Login

If you are a provider and do not yet have an account with us, please call us at 888-250-LUNA (5862) or email us at [email protected].

If you are a patient and not a provider please click here.

About Luna Genetics

Luna Genetics Gradient Background
meet the team

Luna Genetics was founded by physicians and scientists who believed there was a better, safer, and earlier way to test for fetal abnormalities.

The Luna team developed a novel approach called the Luna Prenatal Test. The Luna Prenatal Test uniquely captures fetal trophoblast cells in maternal blood early in pregnancy and uses advanced DNA analysis to detect a range of genetic abnormalities, including Down syndrome, trisomy 13, trisomy 18, and many smaller chromosomal abnormalities.

Luna Genetics

Team Leadership

Arthur Beaudet

Chief Executive Officer and Chief Scientific Officer

Dr. Beaudet is a cofounder, Chief Executive Officer and Chief Scientific Officer of Luna Genetics. He was the Henry and Emma Meyer Chair and Professor of Molecular and Human Genetics at Baylor College of Medicine, Houston TX through 2019. He is a Past President of the American Society of Human Genetics (ASHG) and a member of the National Academy of Medicine and National Academy of Sciences.

Luna Genetics Gradient Background

Arthur Beaudet

Chief Executive Officer and Chief Scientific Officer
Science Advisory Board

Philip Reilly

Cofounder

Dr. Reilly is a cofounder and respected clinical geneticist and a life science entrepreneur. He co-founded Fulcrum Therapeutics, Voyager Therapeutics, Edimer and Lotus Tissue Repair, and served as interim CMO at bluebird bio and Goldfinch Bio. He has been an Overseer of Weill Cornell Medical College, and he serves on the advisory board to the Boston University School of Public Health. Dr. Reilly has served on the Board of Directors at the American Society of Human Genetics (ASHG) and is a Trustee Emeritus of Cornell University.

Luna Genetics Gradient Background

Philip Reilly

Cofounder
Science Advisory Board

Michelle Bellair

Vice President of Clinical Laboratory Operations

Michelle is Director of Clinical Lab Operations at Luna Genetics. Her previous experience includes 6 years at CooperGenomics, where she managed Preimplantation Genetic Testing for Aneuploidy (PGT-A) and lab operations at the Houston lab, as well as development of new tests and assays as part of the R&D team. Michelle also worked as a Project Manager and Technical Lead for the Human Genome Sequencing Center at Baylor College of Medicine. Michelle has extensive experience in preimplantation genetic testing, reproductive genetics, whole exome/genome sequencing, new test development, automation, and LIMS, as well as lab operations, project management, and quality assurance.

Luna Genetics Gradient Background

Michelle Bellair

Vice President of Clinical Laboratory Operations
Science Advisory Board

April O’Connor

Lead Genetic Counselor

Ms. O’Connor is a board-certified Genetic Counselor with over 16 years of experience in prenatal and pre-conception genetics. She is currently the Lead Genetic Counselor at Luna Genetics supporting the launch of a revolutionary form of genetic prenatal diagnosis. In addition, she is working to develop the genetic counseling infrastructure for the enterprise. She received her Master of Science Degree in Genetic Counseling from The University of Arizona in 2005 and her Bachelor of Science Degree in Cytogenetics from Thomas Jefferson University in 2001. She is a diplomat of the American Board of Genetic Counseling and a full member of the National Society of Genetic Counselors.

Luna Genetics Gradient Background

April O’Connor

Lead Genetic Counselor
Science Advisory Board
Luna Genetics

Scientific Advisory Board

Cynthia Morton

Board Chair

Cynthia Morton, Ph.D. is the William Lambert Richardson Professor of Obstetrics, Gynecology and Reproductive Biology and Professor of Pathology at Harvard Medical School, Distinguished Chair in Obstetrics and Gynecology, Director of Cytogenetics and Past Director of the Biomedical Research Institute at Brigham and Women’s Hospital. She is an Institute Member of the Broad Institute. Dr. Morton is a past member of the Board of Directors of the ABMGG and was Chair of the Molecular Genetic Pathology Policy and Exam Committees of the ABMGG and the American Board of Pathology.

Luna Genetics Gradient Background

Cynthia Morton

Board Chair

Ron Wapner

Ronald Wapner, M.D. is the Vice Chair of Research in Obstetrics and Gynecology for Columbia University Irving Medical Center and Director of Reproductive Genetics. Dr. Wapner is an internationally known physician and researcher specializing in reproductive genetics. He pioneered the development of chorionic villus sampling (CVS) and multi-fetal reduction. Dr. Wapner is collaborating with Luna Genetics to provide samples for validation studies.

Luna Genetics Gradient Background

Ron Wapner

Mary Norton

Mary E. Norton, M.D. is Professor and Division Chief, Obstetrics, Gynecology & Reproductive Sciences, and David E. Thorburn, M.D. and Kate McKee Thorburn Endowed Chair in Perinatal Medicine and Genetics, at the University of San Francisco. Her interests are prenatal diagnosis, reproductive genetics, obstetrical ultrasound, genetic screening, chromosomal microarray analysis, cell free DNA analysis, non-invasive prenatal testing, and whole exome/genome sequencing.

Luna Genetics Gradient Background

Mary Norton

Nicholas Navin

Nicholas Navin, Ph.D. is Professor in the Department of Genetics, Division of Basic Sciences at MD Anderson Cancer Center, with a joint appointment in the Department of Bioinformatics. He invented the first single cell DNA sequencing method (Single-Nucleus-Sequencing) for sequencing the genome of a mammalian cell. The Navin laboratory works at the forefront of the single cell cancer genomics field.

Luna Genetics Gradient Background

Nicholas Navin

Our Mission

Our mission is to revolutionize prenatal genetic testing by providing safer, more accurate, and earlier results.

Our Vision

We envision the Luna Prenatal Test as the next generation in prenatal testing for an earlier and safer diagnosis of genetic abnormalities in pregnancy.

Luna Genetics Gradient Background
Luna Genetics

Testimonials

"This test is incredible and will supplant cell-free NIPTs in short order.

Hope the company has the bandwidth to test what is likely to become a flood of samples. The fact that it’s a diagnostic and can take the place of amnio/CVS is a really big deal. Even couples who are enthusiastic about genetic testing have some reservations about these tests due to their invasive nature. The Luna Test changes this."

~Mark Zylka, Ph.D. researcher at UNC working on prenatal CRISPR treatment for Angelman syndrome
"If I’d had the option to take the Luna Prenatal Test to avoid the wait, I would not have hesitated.

After receiving an abnormal screening result from my noninvasive prenatal test (NIPT), I had to wait two months until I could undergo amniocentesis. It turned out the NIPT result was a false positive, but the months of waiting to get a normal diagnostic result on the health of my growing fetus were the two most difficult months of my life."

~Kim S., mother who experienced amniocentesis following an abnormal NIPT result.

See What Makes Our Test Better

CLick Here
Luna Genetics Gradient Background
Luna Genetics

Team Photos

Luna Genetics 07-30-21 06